Market Cap

Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd Market Capitalization:

CN¥10.27 Billion

CNY as of July 1, 2024

US$1.41 Billion

business Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd Company Profile

Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd Main Stock Listing

SZSE: 300357

Market Capitalization History of Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $808.65 B
Johnson & Johnson $350.63 B
Merck $318.75 B
AbbVie $295.34 B
AstraZeneca $236.45 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥14.01 B -51.63%
Jan. 1, 2023 CN¥28.95 B 18.32%
Jan. 1, 2022 CN¥24.47 B -50.47%
Jan. 1, 2021 CN¥49.41 B 92.23%
Jan. 1, 2020 CN¥25.70 B 124.44%
Jan. 1, 2019 CN¥11.45 B 49.20%
Jan. 1, 2018 CN¥7.68 B 34.51%
Jan. 1, 2017 CN¥5.71 B -4.13%
Jan. 1, 2016 CN¥5.95 B 1.97%
Jan. 1, 2015 CN¥5.84 B 37.55%
Jan. 1, 2014 CN¥4.24 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd Categories

China languages Healthcare languages Drug Manufacturers—General
China Healthcare China Drug Manufacturers—General

Stocks & Indices

Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300357

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.